ARS Pharmaceuticals, Inc. (SPRY) quarterly income statement — complete revenue, gross profit & net income history
ARS Pharmaceuticals, Inc. (SPRY) annual income statement — 8-year revenue, gross profit & net income history
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|
| Sales/Revenue | 33.66M | 22.68M | 28.09M | 32.5M | 15.72M | 7.97M | 86.58M | 2.07M | 500K | 0 | 0 | 0 | 10K | 20K | 0 | 189K | 464K | 663K | 754K | 528K |
| Revenue Growth % | 114.15% | 184.47% | -67.56% | 1471.62% | 3043.4% | - | - | - | 4900% | -100% | - | -100% | -97.84% | -96.98% | -100% | -64.2% | -78.03% | -68.61% | - | - |
| Cost of Goods Sold | 12.85M | 6.29M | 3.2M | 8.19M | 4.98M | 4.05M | 3.89M | 112K | 6.9M | 5.23M | 3.4M | 3M | 7.21M | 6.45M | 3.55M | 3.79M | 4.35M | 5.42M | 3.91M | 5.12M |
| COGS % of Revenue | 38.17% | 27.71% | 11.4% | 25.2% | 31.71% | 50.75% | 4.5% | 5.42% | 1379.2% | - | - | - | 72080% | 32260% | - | 2006.88% | 937.5% | 817.95% | 519.1% | 970.08% |
| Gross Profit | 20.81M | 16.39M | 24.89M | 24.31M | 10.73M | 3.93M | 82.69M | 1.96M | -6.4M | -5.23M | -3.4M | -3M | -7.2M | -6.43M | -3.55M | -3.6M | -3.89M | -4.76M | -3.16M | -4.59M |
| Gross Margin % | 61.83% | 72.29% | 88.6% | 74.8% | 68.29% | 49.25% | 95.5% | 94.58% | -1279.2% | - | - | - | -71980% | -32160% | - | -1906.88% | -837.5% | -717.95% | -419.1% | -870.08% |
| Gross Profit Growth % | 93.91% | 317.49% | -69.91% | 1142.84% | 267.81% | 175.03% | 2529.17% | 165.16% | 11.14% | 18.63% | 4.22% | 16.7% | -85.23% | -35.13% | -12.47% | 21.55% | -10.82% | -35.75% | - | - |
| Operating Expenses | 82.28M | 76.54M | 66.35M | 77.5M | 58.35M | 41.1M | 35.49M | 23.7M | 8.94M | 7.96M | 6.82M | 14.98M | 13.4M | 12.28M | 11.89M | 3.03M | 2.46M | 2.34M | 1.8M | 1.02M |
| OpEx % of Revenue | 244.45% | 337.46% | 236.23% | 238.46% | 371.23% | 515.54% | 40.99% | 1146.23% | 1788.8% | - | - | - | 134050% | 61405% | - | 1601.06% | 529.74% | 352.79% | 238.86% | 193.56% |
| Selling, General & Admin | 77.58M | 72.2M | 59.95M | 74.75M | 54.31M | 0 | 0 | 19.28M | 8.94M | 0 | 0 | 0 | 13.4M | 12.28M | 10.83M | 3.03M | 2.46M | 2.34M | 1.8M | 1.02M |
| SG&A % of Revenue | 230.49% | 318.35% | 213.46% | 230% | 345.56% | - | - | 932.35% | 1788.8% | - | - | - | 134050% | 61405% | - | 1601.06% | 529.74% | 352.79% | 238.86% | 193.56% |
| Research & Development | 4.7M | 4.34M | 3.44M | 2.75M | 4.04M | 2.95M | 3.03M | 4.42M | 6.9M | 5.23M | 3.4M | 3M | 7.31M | 6.55M | 4.71M | 3.89M | 4.35M | 5.42M | 3.91M | 5.12M |
| R&D % of Revenue | 13.96% | 19.12% | 12.26% | 8.46% | 25.67% | 37.03% | 3.5% | 213.88% | 1379.2% | - | - | - | 73080% | 32760% | - | 2059.79% | 937.5% | 817.95% | 519.1% | 970.08% |
| Other Operating Expenses | 0 | 0 | 1000K | 0 | 0 | 1000K | 1000K | 0 | -1000K | 1000K | 1000K | 1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K |
| Operating Income | -61.47M | -60.15M | -41.47M | -53.19M | -47.61M | -37.18M | 47.2M | -21.75M | -15.34M | -13.19M | -10.23M | -17.98M | -20.6M | -18.71M | -15.44M | -6.63M | -6.34M | -7.1M | -4.96M | -5.62M |
| Operating Margin % | -182.62% | -265.18% | -147.63% | -163.66% | -302.95% | -466.29% | 54.51% | -1051.64% | -3068% | - | - | - | -206030% | -93565% | - | -3507.94% | -1367.24% | -1070.74% | -657.96% | -1063.64% |
| Operating Income Growth % | -29.09% | -61.78% | -187.86% | -144.58% | -210.39% | -181.81% | 561.54% | -20.97% | 25.54% | 29.5% | 33.78% | -171.16% | -224.76% | -163.6% | -211.29% | -18.06% | -42.93% | -59.94% | - | - |
| EBITDA | -61.05M | -59.75M | -41.05M | -50.84M | -47.34M | -36.9M | 47.23M | -21.73M | -15.32M | -13.18M | -10.21M | -17.96M | -20.58M | -18.69M | -15.19M | -6.62M | -6.34M | -7.05M | -4.75M | -5.61M |
| EBITDA Margin % | -181.38% | -263.43% | -146.15% | -156.43% | -301.17% | -462.77% | 54.55% | -1050.63% | -3064.4% | - | - | - | -205830% | -93465% | - | -3504.23% | -1365.84% | -1063.2% | -630.37% | -1063.26% |
| EBITDA Growth % | -28.97% | -61.93% | -186.92% | -133.99% | -208.93% | -179.93% | 562.37% | -20.99% | 25.56% | 29.49% | 32.75% | -171.13% | -224.78% | -165.19% | -219.53% | -17.97% | -42.83% | -58.87% | - | - |
| D&A (Non-Cash Add-back) | 416K | 397K | 417K | 2.35M | 279K | 280K | 29K | 21K | 18K | 11K | 12K | 21K | 20K | 20K | 255.5K | 7K | 6.5K | 50K | 208K | 2K |
| EBIT | -59.86M | -58.18M | -41.4M | -51.15M | -44.88M | -33.94M | 50.22M | -19.13M | -12.52M | -10.29M | -10.23M | -17.98M | -20.6M | -18.71M | -15.44M | -6.63M | -6.34M | -7.1M | -4.96M | -5.62M |
| Net Interest Income | -874K | -473K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 47K | 0 |
| Interest Income | 1.6M | 1.97M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | - | 47K | 0 |
| Interest Expense | 2.48M | 2.44M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | - | - | 0 |
| Other Income/Expense | -874K | -473K | 61K | 2.04M | 2.73M | 3.24M | 3.02M | 2.62M | 2.82M | 2.9M | 3.06M | 3.11M | 3.23M | 3.75M | 1.01M | 47K | -76K | -151K | -179K | -194K |
| Pretax Income | -62.34M | -60.62M | -41.4M | -51.15M | -44.88M | -33.94M | 50.22M | -19.13M | -12.52M | -10.29M | -7.17M | -14.87M | -17.37M | -14.96M | -14.43M | -6.58M | -6.42M | -7.25M | -5.14M | -5.81M |
| Pretax Margin % | -185.21% | -267.26% | -147.41% | -157.38% | -285.57% | -425.69% | 58.01% | -924.95% | -2503.2% | - | - | - | -173700% | -74805% | - | -3483.07% | -1383.62% | -1093.51% | -681.7% | -1100.38% |
| Income Tax | 0 | 0 | -80K | 0 | 0 | 0 | 288K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0.19% | 0% | 0% | 0% | 0.57% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -62.34M | -60.62M | -41.32M | -51.15M | -44.88M | -33.94M | 49.93M | -19.13M | -12.52M | -10.29M | -7.17M | -14.87M | -17.37M | -14.96M | -14.43M | -6.58M | -6.42M | -7.25M | -5.14M | -5.81M |
| Net Margin % | -185.21% | -267.26% | -147.13% | -157.38% | -285.57% | -425.69% | 57.67% | -924.95% | -2503.2% | - | - | - | -173700% | -74805% | - | -3483.07% | -1383.62% | -1093.51% | -681.7% | -1100.38% |
| Net Income Growth % | -38.89% | -78.6% | -182.76% | -167.41% | -258.61% | -229.77% | 796.62% | -28.67% | 27.94% | 31.21% | 50.32% | -125.82% | -170.56% | -106.36% | -180.72% | -13.3% | -38.17% | -56.03% | - | - |
| Net Income (Continuing) | -62.34M | -60.62M | -41.32M | -51.15M | -44.88M | -33.94M | 49.93M | -19.13M | -12.52M | -10.29M | -7.17M | -14.87M | -17.37M | -14.96M | -14.43M | -6.58M | -6.42M | -7.25M | -5.14M | -5.81M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.63 | -0.61 | -0.42 | -0.52 | -0.46 | -0.35 | 0.51 | -0.20 | -0.13 | -0.11 | -0.07 | -0.16 | -0.18 | -0.16 | -0.15 | -0.07 | -0.07 | -0.08 | -0.15 | -0.17 |
| EPS Growth % | -36.96% | -74.29% | -182.35% | -160% | -253.85% | -218.18% | 783.65% | -25% | 27.78% | 31.25% | 50.27% | -127.92% | -162.77% | -106.99% | 0% | 58.71% | 47.31% | 40.54% | - | - |
| EPS (Basic) | -0.63 | -0.61 | -0.42 | -0.52 | -0.46 | -0.35 | 0.51 | -0.20 | -0.13 | -0.11 | -0.07 | -0.16 | -0.18 | -0.16 | -0.15 | -0.07 | -0.07 | -0.08 | -0.15 | -0.17 |
| Diluted Shares Outstanding | 99.31M | 99.3M | 98.57M | 98.81M | 98.36M | 98.06M | 97.95M | 97.03M | 96.83M | 96.49M | 96.13M | 95.58M | 94.91M | 94.23M | 94M | 93.77M | 93.77M | 93.77M | 35.04M | 35M |
| Basic Shares Outstanding | 99.31M | 99.3M | 98.57M | 98.81M | 98.36M | 98.06M | 97.95M | 97.03M | 96.83M | 96.49M | 96.13M | 95.58M | 94.91M | 94.23M | 94M | 93.77M | 93.77M | 93.77M | 35.04M | 35M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |